Braun Stacey Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,516
| Closed | -$13M | – | 121 |
|
|
2025
Q1 | $13M | Sell |
20,516
-976
| -5% | -$619K | 0.53% | 71 |
|
|
2024
Q4 | $15.3M | Sell |
21,492
-654
| -3% | -$466K | 0.57% | 71 |
|
|
2024
Q3 | $23.3M | Sell |
22,146
-1,172
| -5% | -$1.23M | 0.88% | 46 |
|
|
2024
Q2 | $24.5M | Sell |
23,318
-73
| -0.3% | -$76.7K | 0.95% | 38 |
|
|
2024
Q1 | $22.5M | Buy |
23,391
+1,902
| +9% | +$1.83M | 0.89% | 49 |
|
|
2023
Q4 | $18.9M | Buy |
21,489
+465
| +2% | +$408K | 0.84% | 53 |
|
|
2023
Q3 | $17.3M | Buy |
21,024
+35
| +0.2% | +$28.8K | 0.84% | 52 |
|
|
2023
Q2 | $15.1M | Sell |
20,989
-18,223
| -46% | -$13.1M | 0.7% | 69 |
|
|
2023
Q1 | $32.2M | Buy |
39,212
+19,836
| +102% | +$16.3M | 0.84% | 59 |
|
|
2022
Q4 | $14M | Sell |
19,376
-161
| -0.8% | -$116K | 0.8% | 57 |
|
|
2022
Q3 | $13.5M | Buy |
19,537
+3,348
| +21% | +$2.31M | 0.82% | 56 |
|
|
2022
Q2 | $9.57M | Sell |
16,189
-5,096
| -24% | -$3.01M | 0.55% | 80 |
|
|
2022
Q1 | $14.9M | Sell |
21,285
-733
| -3% | -$512K | 0.62% | 81 |
|
|
2021
Q4 | $13.9M | Buy |
22,018
+73
| +0.3% | +$46.1K | 0.51% | 90 |
|
|
2021
Q3 | $13.3M | Buy |
+21,945
| New | +$13.3M | 0.53% | 89 |
|
|
2017
Q1 | – | Sell |
-26,597
| Closed | -$9.76M | – | 152 |
|
|
2016
Q4 | $9.76M | Buy |
26,597
+1,214
| +5% | +$446K | 0.64% | 80 |
|
|
2016
Q3 | $10.2M | Buy |
25,383
+2,059
| +9% | +$828K | 0.65% | 81 |
|
|
2016
Q2 | $8.15M | Sell |
23,324
-1,922
| -8% | -$671K | 0.53% | 93 |
|
|
2016
Q1 | $9.1M | Sell |
25,246
-5,967
| -19% | -$2.15M | 0.59% | 88 |
|
|
2015
Q4 | $16.9M | Buy |
31,213
+11,714
| +60% | +$6.36M | 1.06% | 39 |
|
|
2015
Q3 | $9.07M | Buy |
+19,499
| New | +$9.07M | 0.61% | 88 |
|